Open-label, phase IIIb, multicenter, expanded access study of everolimus in patients with advanced neuroendocrine tumors (NET).

Authors

BECHTER Oliver Edgar UNGER Nicole BORBATH Ivan RICCI Sergio HWANG Tsann-Long PARK Young Suk TOMÁŠEK Jiří RAEF Hussein

Year of publication 2013
Type Appeared in Conference without Proceedings
Citation

You are running an old browser version. We recommend updating your browser to its latest version.

More info